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Nutritional support is becoming more widely acknowledged as a crucial component of the
key package of care for HIV/AIDS patients. This nutritional support is exceptionally impor-
tant for patients in sub-Saharan Africa, including Ethiopia, where HIV/AIDS is very preva-
lent. However, there is a lack of evidence on the recovery rate and predictors at the study
site and at large in Ethiopia. Therefore, this study will give some insight into the recovery
rate and its predictors among under-nourished HIV-positive adults treated with Ready to
Use Therapeutic Food (RUTF) attending at Debre Markos referral hospital. Moreover, the
findings of this study will be used by both governmental and non-governmental organiza-
tions to allocate more resources to mitigate the nutritional problems for people living with
HIV.
Methods
An institution-based retrospective cohort study was conducted among 453 under-nourished
HIV positive adults treated with RUTF at Debre Markos referral Hospital from the 1st of July,
2015 to the 31st of December, 2017. The study participants were selected using a simple
random sampling technique. Data were extracted from patient charts using a standardized
data extraction checklist. Data were entered into Epi-Data Version 4.2 and analyzed using
Stata Version 14. The Kaplan-Meier survival curve was used to estimate the time to recov-
ery. Log-rank test was used to compare the recovery time between different baseline cate-
gorical variables. The bivariable and multivariable Cox-proportional hazard regression
models were fitted for potential predictors of recovery time. Adjusted hazard Ratios (AHRs)
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with 95% CIs were used to measure the strength of association and test statistical
significance.
Results
A total of 453 undernourished HIV-positive adults were included in the final analysis. About
201, 44.4% (95%CI: 38.9, 49.0%) patients participating in the RUTF program were recov-
ered based on predetermined exit criteria with incidence of 10.65 (95% CI: 9.28, 12.23) per
100 person-month observations. Being moderately undernourished (AHR: 11.0, 95% CI:
5.3, 23.1), WHO clinical stage (I or II) (AHR:1.8, 95% CI: 1.2, 2.6), and working functional
status at baseline (AHR = 2.34, 95%CI: 1.01,5.45) were predictors of recovery time.
Conclusion
This study concluded that the overall nutritional recovery rate was below the acceptable
minimum requirement which at least 75% of patients should recovered. Mild to moderate
undernutrition at baseline, WHO clinical stage I or II at enrolment, and working functional
status were found to be predictors of recovery time in HIV/AIDS patients treated with the
RUTF. As a result, special attention should be paid to severely malnourished patients, WHO
clinical stages III or higher, and patients who are bedridden or ambulatory during treatment.
Introduction
In 2019, around 38 million people worldwide were infected with HIV with 1.7 million of them
were newly infected [1]. According to HIV-related estimations and projections for 2019, about
860, 000 persons in Ethiopia were living with HIV, with adults accounting for the largest share
with a prevalence rate of 0.9 percent [2].
HIV and malnutrition are closely linked and have a synergetic effect on one another [3–5].
Malnutrition is dramatically increased by HIV. Malnutrition on the other hand, has been
shown to hasten the progression of HIV to AIDS [5,6]. They have the potential to harm the
immune system and increase infection susceptibility, morbidity and mortality [3,5]. Undernu-
trition among HIV-positive people is a major public health concern worldwide, particularly in
Sub-Saharan Africa (SSA) [7].
Dietary methods such as RUTF have been demonstrated to be effective in addressing
undernutrition in HIV patients [8–11]. RUTF is a Plumpynut1-based paste (Plumpy nut or
Plumpy sup) in a plastic wrapper for treatment of under nutrition. Peanut-based paste with
sugar, vegetable, fat and skimmed milk are among the constitutes of Plumpy nut or Plumpy
sup [12]. This therapeutic food is prescribed for a defined period of time, usually 3–6 months,
based on anthropometric admission and exit criteria [13].
Adults with mild to moderate acute malnutrition (MAM) and severely acute malnutrition
(SAM) should receive therapeutic food, such as RUTF, which is nutritionally similar to F-100,
according to WHO guidelines [14]. The food by prescription program (FBP) provides under-
nourished HIV positive people with food and nutritional support in the form of therapeutic
and supplementary feeding, as well as nutritional assessment and counseling at health facilities.
The initiative was created to fill dietary intervention gaps in HIV palliative care and assistance
for disadvantaged groups, as well as to supplement the antiretroviral therapy (ART) program
[9,15].
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FBP has been implemented by the Ethiopian government from 2010 with UNICEF and
USAID/Ethiopia collaborating with the Ethiopian Ministry of Health and HIV/AIDS Preven-
tion and Control Office, as well as the Food and Nutrition Technical Assistant (FANTA) pro-
gram [15]. Adult HIV positive patients with MAM receive two sachets of RUTF daily for a
minimum of three and a maximum of four months, while those with SAM receive four sachets
daily for a minimum of six months and a maximum of eight months under this component of
the program [16].
The recovery rate of patients on RUTF were influenced by a variety of factors. Several stud-
ies have found that socio-demographic predictors (gender, age, educational level) [16,17], clin-
ical and immunological factors (WHO stages (stage I and II), absence of opportunistic
infection, CD4 cell percentage above the threshold, ART status, and baseline nutritional status)
have an effect on the Recovery rate [16,18–21]. However, almost all of these studies did not
considered censored time to estimate unbiased population parameter at each instantaneous
time. The research presented in this report seeks to contribute to filling these gaps identified in
the literatures. Several studies have also provided evidence on the recovery time of HIV/AIDS
patients treated with RTUF varied. The median recovery duration was 3.7 months (IQR 2.2–
6.1) in a long-term study done at SSA [19]. According to another Kenyan study, the median
recovery time was 100 days [20]. In Ethiopia, however, a joint study by Tufts University and
Save the Children found that the average recovery period for SAM and MAM patients to
restore excellent nutritional status and meet discharge requirements was four months and two
months, respectively [16].
Many research on the undernourished HIV positive adults have been undertaken in many
regions of the world, and they have found that the problem is particularly prevalent in SSA,
including Ethiopia. However, there was a paucity of evidence on the optimal recovery duration
and determinants among undernourished HIV positive people in Ethiopia who were treated
with RUTF, particularly at the research site. As a result, the recovery rate and its determinants
among undernourished HIV positive people treated with RUTF at Debre Markos referral hos-
pital will be explored in this study. Furthermore, the findings of this study will be used by both
governmental and non-governmental sectors to devote additional resources to help persons
living with HIV with their dietary needs.
Methods
Study area and period
An Institution-based retrospective cohort study was conducted at Debre Markos Referral Hos-
pital from the 1st of July, 2015 to the 31st of December, 2017. Debre Markos is the zonal capital
of East Gojjam zone. It is located Northwestern Ethiopia, in Amhara Regional State, East Goj-
jam zone, at a distance of 300 kilometers from Addis Ababa, the capital city of Ethiopia, and
265 kilometers from Bahirdar the regional capital. Debre Markos Referral Hospital provides
service for More than five million people in its catchment area [22]. Since the beginning of
antiretroviral therapy (ART) at Debre Markos referral hospital, a total of 9,612 HIV patients
have enrolled in the treatment. Currently, about 3,702 patients are on ART at the hospital, of
whom 3,375 are male. A total of 1,442 HIV-positive adults were nutritionally assessed and
determined to be clinically undernourished, with around 980 people receiving therapeutic
nutrition [23].
Source population
All under-nourished HIV positive adults treated with ready-to-use therapeutic food at Debre
Markos Referral Hospital.
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Study population
All under-nourished HIV positive adults treated with ready-to-use therapeutic food from the
1st of July, 2015 to the 31st of December, 2017 at Debre Markos Referral Hospital.
Exclusion criteria
Cases with no charts available at the time of data collection were excluded. Patients with miss-
ing baseline data (nutritional status, height, weight, MUAC (for pregnant/bedridden)) were
also omitted. Patients who had edema were also omitted since the measurements for the out-
come variable would be altered.
Sample size determination
The sample size was estimated based on the objectives. For estimating the recovery rate a single






When, n = sample size; d = tolerable marginal error; P = the proportion of nutritional
recovery rate from previous study (0.62) [18]. Hence, with 95% confidence level (Z = 1.96) and
5% precision. Finally, after adding 10% for incompleteness of cards, the required sample size
for determining the recovery rate was 398. For the second objective, the sample size determi-
nation for predictors of treatment recovery rate from nutritional program was calculated using
double population proportion formula by using Epi Info version 7 (Centers for Disease Con-
trol and prevention) statically programs by considering 95%CI, power 80% and 10% lose to
follow up (Table 1). The ration for exposed to non-exposed group is 1 to 1 for this study.
Accordingly, the maximum sample size based on the above two formulae after considering
10% incompleteness was 398 and 453. For better estimate of parameters, the maximum sample
size of 453 was used.
Sampling procedure
After computing the minimum adequate sample size, the medical registration numbers of
under-nourished HIV positive adults treated with RUTF from the 1st of July, 2015 to the 31st
of December, 2017 in the study hospital was recruited. Each patient’s record was chosen using
a basic random sample procedure with a list of medical registration numbers as sampling
frame. The patient charts were chosen using a computer-generated algorithm.
Table 1. Sample size calculation to assess the recovery rate and its predictors among under-nourished HIV positive adults treated with ready-to-use therapeutic
food at Debre Markos Referral Hospital, Northwest Ethiopia, 2018. (CI:95%, Power = 80%).
Predictors Risk ratio Proportion Sample size Total sample size after adding 10%
Exposed Un exposed
Female sex [18] 1.26 67.0 53 412 453
Mild malnutrition [18] 2.18 79.4 36.3 48 52
WHO clinical stage I and II [18] 1.48 83.6 56.2 100 110
Absence of OI [18] 2.07 64.6 31.2 80 88
https://doi.org/10.1371/journal.pone.0255465.t001
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Study variables
The dependent variable was recovery rate from under nutrition. The independent variables
were socio-demographic variables (Age, sex, residency, marital status, religion, employment
and educational status); clinical and immunological (CD4 cell count or percentage, Hgb,
WHO stages, functional status, ART adherence, types of ART medication regimen anti TB
drugs, TB and other opportunistic infections and preventive therapies (CPT and IPT));
anthropometric measures (BMI, MUAC, Weight and Height).
Definition of study variables
Event: Recovered from under-nutrition who was treated with ready–to-use therapeutic food.
SAM; HIV positive adults whose baseline BMI< 16kg/m2 or MUAC <19cm for Pregnant/
bedridden [14,24].
MAM; HIV positive adults whose baseline BMI relay between 16kg/m2� BMI<18.5kg/m2
or 19�MUAC<23 cm for pregnant/bedridden [14,24].
Ready- to -use therapeutic food; is a Plumpynut1-based paste (Plumpy nut or Plumpy
sup) in a plastic wrapper for treatment of under nutrition. The ingredients in Plumpy nut or
Plumpy sup include "peanut-based paste, with sugar, vegetable, fat and skimmed milk powder,
enriched with vitamins and minerals" with energy 2,100 kJ (500) kcal in 92 grams [12].
Recovered; under-nourished HIV positive adult reaching BMI of�18.5 kg/m2 within the
course of therapy or MUAC� 23cm for pregnant/bedridden [24].
Censored; Patients who were on RUTF but un recovered at the end of the study, dead, and
defaulted participants were considered as censored.
Defaulter: Participant did not reach a BMI of 18.5 and dropped out of the program before
the end of three (MAM) or six (SAM) months [16].
CD4 count: was classified as below the threshold (CD4 count< 200 cells/mm3 or percent-
age<15%) and above the threshold (CD4 count�200 cells/mm3 or percentage�15%) for
severe immunodeficiency [25].
ART adherence: Good-if the percentage of missed dose is> 95%(< 2 doses of 30 dose or
<3 doses of 60 doses); Fair-if the percentage of dose between 85–94%(3–5 doses of 30 doses 30
dose or 4–8 doses of 60 dose); poor- if dose < 85%(> = 6 doses of 30 doses or > = 9 doses of
60 doses) documented by ART physician [25].
Data collection tool and procedure
This study used secondary data that were collected using structured data extraction checklist.
Patient’s chart and ART registration book were used as a source of data for this study. At each
patient’s chart visit, individual HIV and nutritional data were routinely collected on standard-
ized forms. The most recent laboratory test results prior to RUTF initiation were used as a
baseline value. If there were no laboratory tests registered prior to RUTF intake, results
obtained within one month of RUTF initiation were used as a baseline. If two results were
obtained within one month, the mean value was used. Data collection tool included socio
demographic characteristics, clinical and immunological information, anthropometric mea-
surements, RUTF enrolment dates, the presence or absence of OIs diagnosed and NP outcome
(categorized as recovered, not recovered, defaulted).
Data quality control
The data were collected by two experienced ART BSc nurses who were trained on comprehen-
sive HIV care and currently involved in the follow up care. The entire data collection process
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was closely supervised by one supervisor. One-day training was given for both data collectors
and supervisor concerning data extraction checklist and data collection process separately.
The filled checklist was checked for their completeness, consistency and accuracy during data
management, storage and analysis by the principal investigator.
Data processing and analysis
The data were entered into Epi-data version 4.2 and analysis was done using STATA version
14. Before analysis, data were cleaned and edited. Results were organized and presented using
tables and texts. Patients’ cohort characteristics of continuous data were described in terms of
central tendency (mean or median), dispersion (standard deviation or inter quartile range)
and in frequency distribution for categorical data. The Kaplan-mire survival curve and Log
rank test were used to estimate the time to recovery and to compare the survival curves across
baseline categorical variables. Both bivariable and multivariable Cox-proportional hazard
regression models were fitted to identify independent predictors of recovery rate. In the bivari-
able analysis, variables having p-value less than or equal to 0.25 were fitted into the multivari-
able analysis. Finally, in the multivariable analysis variables having p-value less than 0.05 were
considered as predictors of recovery. The necessary Cox-proportional hazard regression
model assumption was checked by using Schoenfeld residual test. Adjusted hazard Ratio
(aHR) with 95% CI were used to report strength of association and statistical significance.
Ethical considerations
Ethical clearance was obtained from Debre Markos University, Collage of Health Sciences eth-
ical review committee. In addition, formal letter was secured from Debre Markos Referral
Hospital administration. As this was a retrospective study, verbal or written consent from the
patient was not applicable. To keep confidentiality, the patient names and unique ART num-
ber were not included in data collection format. Moreover, the collected data were coded and
locked into a separate room before data entry. Furthermore, the data were not disclosed to
anyone other than principal investigator. Finally, all the data collected was kept confidential,
and would not be used for any other purposes than the stated research objective.
Results
Baseline socio-demographic characteristics of patients
The final analysis comprised a total of 453 patient records. More than half of the study partici-
pants, 273 (60.3%), were females. The majority of them, 435 (96%) were orthodox Christians,
and almost two-thirds,288 (63.6%) came from urban areas. The respondents’ average age was
36.20.42 SD years (Table 2).
Clinical, nutritional and HIV/AIDS related characteristics of patients
The RUTF program enrolled a total of 453 HIV-positive persons who were malnourished. At
the time of enrolment, 367 (81%) were classed as mild to moderately undernourished. Only
around 38 (8.9%) of the study participants were ambulatory and bedridden by functional level,
while around 211 (46.6%) had opportunistic infection. The majority of the study subjects,405
(89.4%) exhibited good adherence to ART (Table 3).
Recovery rate of under nourished HIV positive adults treated with RUTF
A total of 453 HIV-positive people on RUTF were observed for varying lengths of time, rang-
ing from 2 to 9 months, with a median follow-up period of 3.94 (IQR:3.64–4.5) months,
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resulting in a total of 1886.16 person-months observations. Approximately, 201 (44.4%) of the
453 patients participating in the RUTF program were recovered according to the predeter-
mined exit criteria. The overall recovery rate was found to be 10.65 (95% CI: 9.28, 12.23) per
100 person-month observations (Table 4).
At four, six, and eight months after starting RUTF, the probability of recovery was 0.65
(95% CI:0.6,0.7), 0.37 (95%CI:0.31,0.43), and 0.25 (95%CI:0.17,0.34), respectively (Table 5).
The overall media estimated recovery time was 4.76 months (95% CI: 4.17, 5. 02 months)
(Fig 1).
The estimated median recovery time was varied depending on the baseline characteristics
of cohort patients. Patients with mild to moderate nutritional status at baseline had a faster
recovery time, with an estimated recovery time of 4 months (95%Cl: 3.80, 4.98 months), com-
pared to severely undernourished patients, who had an estimated recovery time of 7.75 months
(95%CI: 4.89, 7.98 months) (Fig 2).
In terms of estimated recovery time by WHO clinical stage, patients with WHO clinical
stages I or II had an estimated median recovery time of 4.01 months (95%CI: 3.97, 4.13
months) at the baseline, compared to patients with WHO clinical stages III or IV who had a
median recovery time of 7.98 months (95%CI: 6.72, 8.3 months) (Fig 3).
Predictors of recovery time
CD4 count above the threshold, WHO stage I or II, working functional level, mild to moder-
ately undernourished at baseline, absence of OI, and good ART adherence were associated
with shorter recovery time in the bivariable Cox-regression. Only three factors were revealed
to be predictive of recovery in the multivariable Cox-regression. Patients with WHO clinical
Table 2. Socio-demographic characteristics of participants who were treated with RUTF at Debre Markos Referral Hospital from July of 1st, 2015 –December of
31st, 2017.
Variables Categories Frequency (N) Percent (%)
Gender Male 180 39.7
Female 273 60.3
Age (years) 15–29 104 23.0
30–44 257 56.7
�45 92 20.3
Residence Urban 288 63.6
Rural 165 36.4




Educational Status No formal education 156 34.4
primary 105 23.2
Secondary 125 27.6
Tertiary and above 67 14.8
Religion Orthodox 435 96.0
Other† 18 4.0
Employment status Employed 81 17.9
Un employed 372 82.1
† Other religions includes Muslims, Protestants and Catholics.
https://doi.org/10.1371/journal.pone.0255465.t002
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Table 3. Clinical, nutritional and HIV/AIDS related characteristics patients at Debre Markos Referral Hospital
from July of 1st, 2015 to December of 31st, 2017.
Variables Frequency (N) Percent (%)
Baseline nutritional status
Mild to moderate 293 64.7
Sever 160 35.3
WHO clinical stage
WHO stage I and II 258 57.0
WHO stage III and IV 195 43.0
CD4 count
Below the threshold 65 14.4
Above the threshold 388 85.6
Hgb at admission
<12g/dl 121 26.7














Table 4. Recovery rate at particular time interval of HIV/ADIS adult patients treated with RUTF at Debre Markos Referral Hospital from July of 1st, 2015 to
December of 31st, 2017.
Follow-up interval Person-months Failures Recovery rate 95% CI
(0–2] 906.00 0 0.00
(2–4] 780.01 136 17.43 14.73–20.62
(4–6] 169.25 55 32.49 24.94–42.32
(6–8] 29.87 9 30.12 15.67–58.89
>8 1.02 1 98.18 13.83–69.02
Total 1886.16 201 10.65 9.28–12.23
https://doi.org/10.1371/journal.pone.0255465.t004
Table 5. Life table for recovery rate of under nourished HIV positive adults treated with RTUF at 3, 4, 6 and 8 months at Debre Markos referral hospital from July
of 1st, 2015 –December of 31st, 2017.
Time interval (month) Beginning total(N) Recovery status Probability of recovery 95% CI
Recovered(N) Un recovered(N)
3–4 453 133 136 0.65 [0.60,0.70]
4–6 184 59 93 0.37 [0.31,0.43]
6–8 32 7 22 0.25 [0.17,0.34]
8- 3 2 1 0.05 [0.001,0.27]
https://doi.org/10.1371/journal.pone.0255465.t005
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stage I or II at the time of enrolment had a recovery time that was nearly two times shorter
than their counterparts [AHR = 1.99 (95%CI:1.33,2.98)]. Patients with modest to moderate
nutritional status at baseline had a nearly four-fold shorter recovery time [AHR = 3.94(95%
CI:2.67,5.82)] than severely undernourished patients (Table 6).
Discussion
People living with HIV frequently suffer from malnutrition. Nutritional support in the form of
readily to use therapeutic food has been given to these patients on a regular basis to combat
the wasting syndrome caused by the chronic debilitating infection [26]. The provision of sup-
plemental foods over considerable duration of time is thought to cause weight gain and
improve HIV patients’ functioning. As a result, we set out to assess the recovery rate and its
determinants among undernourished HIV positive people treated with RUTF at Debre Mar-
kos referral hospital in this retrospective follow-up study.
In this study, 44.4%(95%CI: 38.9, 49.0%) of 453 patients participating in the RUTF program
were recovered based on predetermined exit criteria. This result was in line with a survey from
SSA nations, which found 47.4 percent [19]. However, the recovery rate by percentage
Fig 1. The overall Kaplan-Meier recovery curve with 95% confidence interval of under nourished HIV positive adults treated with RUTF at Debre
Markos Referral Hospital from July 1st, 2015 –December 31st, 2017.
https://doi.org/10.1371/journal.pone.0255465.g001
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reported in this study is higher than the 35.3 percent reported in a study from Gondar Univer-
sity Hospital in Northwest Ethiopia [17]. The recovery rate, on the other hand, is lower than
the 62.4 percent reported in a research from Mekele Hospital in Northern Ethiopia [18]. Varia-
tions in the sample size, the features of the study population, the quality of service offered,
nutritional assessment methodologies, research area, and the nutritional and HIV related fea-
tures of the study participants could all be reasons for the variance in the recovery rate.
The lower recovery rate reported from Gondar University Hospital could be attributable to
the fact that the study group included both children and adults, whereas the current study
focuses solely on HIV/AIDS-infected adults who are malnourished. Another reason for the
higher recovery rate in our study could be because all participants received integrated ART
and RUTF services, whereas only 68.1 percent of patients on ART were engaged in RUTF,
according to a study conducted in Gondar [17]. This conclusion was supported by results
from a randomized control trial research in Africa that looked at the effect of RUTF on mortal-
ity in HIV-infected people on ART who were highly immunocompromised [27].
The increased proportion of opportunistic infection in our research participants could be
one explanation for the decreased nutritional recovery rate in our study as compared to the
study conducted at Mekele. In our study, 46.6 percent of study participants had opportunistic
Fig 2. The estimated Kaplan-Meier recovery curves of under nourished HIV positive adults treated with RUTF by baseline nutritional status at Debre
Markos Referral Hospital from July of 1st, 2015 to December of 31st, 2017.
https://doi.org/10.1371/journal.pone.0255465.g002
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infections, whereas only 6.1 percent of study participants had OIs in a research conducted at
Mekele Hospital [18].
In terms of nutritional recovery time, the study participants in our study had a median
recovery period of 5 months (IQR:3, 8). This finding is consistent with a research out of Kenya
that found a median recovery time of 100 days [20]. Another SSA study discovered that the
average length of recovery was 3.3 months [19]. The initial reaction to RUTF, on the other
hand, was found to be a considerably increased in MUAC value after 4th and 6th months of
therapy, according to a study from Gondar University Hospital [17]. The delayed initial
response time to recovery at Gondar was due to the method used to assess nutritional recovery
to the normal MUAC value. Using MUAC to assess nutritional status for adults may take
more time than BMI to reach the normal value. In addition BMI is preferable over MUAC to
assess nutritional status for adults though MUAC preferred for special populations like preg-
nant and bedridden patients [24].
This study identified predictors of recovery time from malnutrition in the study partici-
pants. In this study, persons living with HIV who were mild to moderately undernourished at
the start had a faster recovery time when treated with RUTF. Previous research conducted
somewhere in Ethiopia (a collaboration study by Tufts University and Save the Children) and
Fig 3. The estimated Kaplan-Meier recovery of under nourished HIV positive adults treated with RUTF by WHO clinical stages at Debre Markos
Referral Hospital from July of 1st, 2015 –December of 31st, 2017.
https://doi.org/10.1371/journal.pone.0255465.g003
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at Mekele hospital backed up this claim [16,18]. Similar findings were also reported from sub-
Saharan African countries [19,20]. This shorter recovery time among mild to moderately
undernourished patients than severe acutely undernourished patients; could be due to the rea-
son that they possessed a mean BMI of 17.29 kg/m2 (95%CI: 17.23–17.35) which is very close
to attain normal nutritional status (BMI� 18.5kg/m2) as compared to severe acutely under-
nourished patients having a mean BMI 15.19kg/m2 (95%CI: 15.02–15.37) which was far away
from the normal BMI value and therefore, had lower chance of recovery.
Our research also found that people who were in WHO clinical stage I or II at the baseline
had a faster recovery time. A study conducted at Mekele Hospital substantiated this conclusion
[18]. End-stage HIV patients typically experience weight loss as a result of the virus. When the
WHO clinical stage advances to WHO clinical staging III and IV, the number of comorbidities
increases, as does the occurrence of concomitant infections and neoplasms, all of which con-
tribute to a longer recovery period [28]. Furthermore, a study conducted in South Africa
revealed that the rate of weight gain in stage IV of HIV infection was much slower than in
stage I infection [21].
Furthermore, the current research discovered that having a working functional status at
baseline was a substantial predictor of recovery rate. Patients who had a working functional
status at the start of the study recovered faster than those who were ambulatory or bedridden.
This could be explained by the inability of bedridden and ambulatory patients to take RUTF
on time, as well as the incidence of concomitant disease, may cause them to take longer to
recover from undernutrition.
Table 6. Bivariable and multivariable Cox regression of predictors for recovery rate among adults with HIV/AIDS treated with RTUF at Debre Markos Referral
Hospital from July 1st, 2015 to December 31st, 2017.
Variables Nutritional outcomes CHR�(95%CI) AHR��(95%CI)
Recovered (n) Unrecovered (n)
Age(years) 15–29 48 56 1.53(0.97,2.41) 1.29(0.81,2.05)
30–44 122 135 1.40(0.94,2.08) 1.40(0.93, 2.10)
� 45 31 61 1 1
Residence Urban 136 152 1.22(0.90,1.64) 0.86(0.63,1.17)
Rural 65 100 1 1
Employment Employed 46 35 1.42(1.02,1.98) 1.18 (0.84, 1.60)
Unemployed 155 217 1 1
CD4 count Below the threshold 23 42 1 1
Above the threshold 178 210 2.03(1.29, 3.19) 1.40 (0.83, 2.37)
WHO clinical stage stage I or II 154 104 3.05(2.19,4.24) 1.70 (1.13,2.55)
Stage III or IV 47 148 1 1
Functional status Working 194 221 3.77(1.77,8.04) 3.33(1.38,8.01)
Ambulatory 7 31 1 1
Nutritional status Mild to moderate 156 137 4.35 (3.0,6.3) 3.94 (2.67,5.82)
Sever 115 45 1 1
Experience of OIs Yes 59 152 1 1
No 142 100 2.32(1.71, 3.15) 1.08 (0.74,1.58)
ART adherence Good 193 212 3.39(1.67,6.88) 1.72 (0.83, 3.54)
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This research is not without limitation. The study design, being retrospective cohort may
limit our ability to abstract data about predictors that may directly influence the recovery rate
from under nutrition, for instance predictors like food sharing at household level, number of
persons in the household, additional source of income, daily dose of RUTF prescribed and etc.
In addition, the study is a mono center study which may not represent evidence in country
level.
Conclusion
This study concluded that the overall nutritional recovery rate was below the acceptable mini-
mum requirement which at least 75% of patients should recovered. Mild to moderate under-
nutrition at baseline, WHO clinical stage I or II at enrolment, and working functional status
were found to be predictive of recovery time in HIV/AIDS patients treated with the RUTF. As
a result, special attention should be paid to severely malnourished patients, WHO clinical
stages III or higher, and patients who are bedridden or ambulatory during treatment. Mild to
moderately undernourished at baseline. Furthermore, a prospective cohort study should be
done to produce data concerning potential factors that may have a direct impact on recovery,
such as food sharing at the household level, family size, supplementary source of income, daily
dose of RUTF prescribed, and so on.
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